Greetings I was referred here by private email this AM
I am known as delphi, assistant on the MUCL board (MultiCell Technologies), and apparently follow your investment style in regards to having patience in holding shares for long term gain.
We have a stock opening at .42 this morning, up 30% last week based on the company's newfound opennes to promoting itself, up more than 100% since Jan. 1. I wouldn't mention it to you if I didn't believe the company is about receive an entire re-evaluation of its market cap and go much higher in price. It has quite a story to tell, which I have tried to present in a series of HIGHLIGHTED posts over the weekend.
Keywords: Adult Liver Stem Cells, Drug toxicity screening, artificial liver machine, Therapeutic Protein manufacture, partners named Pfizer and XenoTech, with Bristo-Myers Squibb recently confirming Pfizer research.
